Andrés de la Rocha-Muñoz

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 1

Top Topics

Atopic Dermatitis

Dendritic Cells

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Cristina Benito-Villalvilla, Andrés de la Rocha-Muñoz, Jacobo López-Abente, Alexander Eggel, Iván Bottoli, Thomas Severin, Maximilian Woisetschläger, Óscar Palomares
Ligelizumab impairs IgE-binding to plasmacytoid dendritic cells more potently than omalizumab and restores IFN-α production and FOXP3 + Treg generation. Allergy (2022)